CME Group to Expand Crypto Derivatives Suite with Launch of Cardano, Chainlink and Stellar Futures
By Dominic Sow · 11 February 2026

WHY THIS MATTERS:
Regulated crypto derivatives are becoming a cornerstone of institutional and sophisticated retail participation as digital assets mature into a recognised asset class. As volatility remains a defining feature of crypto markets, demand is rising for risk management tools that sit within established regulatory frameworks. Expanding futures coverage beyond Bitcoin and Ether reflects a broader shift toward diversified crypto exposure and more granular hedging strategies. The introduction of both micro and larger contracts is particularly significant, lowering capital barriers while supporting professional trading and portfolio construction. As crypto becomes more embedded in mainstream investment strategies, regulated derivatives are increasingly shaping price discovery, liquidity and market stability across the digital asset ecosystem.
CME Group, the world's leading derivatives marketplace, today announced plans to expand its leading suite of regulated Cryptocurrency derivatives with the launch of Cardano (ADA), Chainlink (LINK) and Stellar (Lumens) futures on February 9, pending regulatory review.
Market participants will have the choice to trade both micro-sized and larger-sized contracts:
- ADA futures (100,000 ADA) and Micro ADA futures (10,000 ADA)
- LINK futures (5,000 LINK) and Micro LINK futures (250 LINK)
- Lumens futures (250,000 Lumens) and Micro Lumens futures (12,500 Lumens)
- Record futures and options average daily volume (ADV) of 278,300 contracts ($12 billion notional) and record average open interest (OI) of 313,900 contracts ($26.4 billion notional)
- Record futures ADV of 272,200 contracts ($11.7 billion notional) and record average OI of 253,600 contracts ($21.4 billion notional)
- Record options ADV of 4,100 contracts ($231 million notional) and average OI of 60,400 contracts ($5 billion notional)
Companies in this story: NinjaTrader, CME Group
People in this story: Martin Franchi